8/19/2019 IAPM2
1/2
INDIAN PHARMA INDUSTRY IS HIGHLY FRAGMENTED:
The Indian pharma industry is highly fragmented and has
grown enormously in the last 20 years.
This industry is highly dependent on science and technology. It
is assumed that there are around
24000 players in this segment and around 330 in the organised
sector.
The organised pharma industry has been growing at about eight to
nine per cent annually. India is
among the top five pharma emerging markets. There are provisions
for phase II clinical trials and
new drug launches in the coming year. Continued growth in
therapies and epansion in rural
market! the Indian pharma industry is epecting a growth of "3#"4
per cent. The domestic
pharma market is epected to grow because of increasing
population of the higher income group.
It is estimated that the healthcare industry in India may touch
$3".%& billion by 2020.
'ource(
http())www.financialepress.com)article)pharma)management*pharma)impact*of*it*on*
indian*pharma*industry)%+%%2)
GROWTH DRIVERS:
The market si,e ofo inidan pharme industry was -' "2.+ billion
in 200& and has the potential
to grow upto -' %% billion in 2020. /ven in the pessimistic
scenario it is epected to reach
-' 3% billionn in the year 2020. In aggressive growth scenario
the industry has potential to
reach -' 0 billion dollars by 2020.
The following are the growth drivers of indian pharma
industry(
". 1opulation growth at around ".3 percent every year and a
steady rise in disease
prevalence will increase the patient poolby nearly by 20
in the year 2020.
2. The affordability of drugs will increase due to steady
increase in the incomes and
increase in insurance coverage. ising incomes will drive 3
million households into
middle and upper income segment. y 2020 nearly +%0 million
people will en5oy health
insurance coverage.
3. 6ccessability of drugs will epand due to growth in medical
infrastructure! new business
models for tier*II towns and rural areas! launches of patents
and products! and a greatergovernment spending on healthcare.
7edical infrastructure will eperience draatic
growth over the net decade! with over -' 200 billion being
investeed in creating and
upgrading medical infrastructure.
4. The acceptability of modern medicine and newer therapies will
increase due to aggressive
market creation by players! an increased acceptance of biologics
and preventive
http://www.financialexpress.com/article/pharma/management-pharma/impact-of-it-on-indian-pharma-industry/56552/http://www.financialexpress.com/article/pharma/management-pharma/impact-of-it-on-indian-pharma-industry/56552/http://www.financialexpress.com/article/pharma/management-pharma/impact-of-it-on-indian-pharma-industry/56552/http://www.financialexpress.com/article/pharma/management-pharma/impact-of-it-on-indian-pharma-industry/56552/
